13/11/19 Baytacare Pharmaceutical Co., Ltd. Reports Earnings Results for the Third Quarter Ended September 30, 2019 CI
23/10/19 Baytacare Pharmaceutical Co., Ltd. Announces the Resignation of Shi Peng as a Non-Executive Director CI
17/09/19 Baytacare Pharmaceutical Co., Limited Announces Resignation of Lam Kai Yeung as the Company Secretary CI
12/08/19 Baytacare Pharmaceutical Co., Ltd. Reports Earnings Results for the Second Quarter Ended June 30, 2019 CI
02/08/19 Baytacare Pharmaceutical Co., Ltd. Establishes an Independent Board Committee of Board of Directors CI
01/07/19 Baytacare Pharmaceutical Co., Ltd. Announces Change of Directors and Change of Composition of Board Committees CI
01/07/19 Baytacare Pharmaceutical Co., Ltd. Announces Change of Registered Address CI
21/06/19 Baytacare Pharmaceutical Co., Ltd. completed the acquistion of 70% stake in Hubei Taofuan Electronics Commerce Co., Ltd. from Taofuan Holdings Co., Ltd. CI
10/06/19 Baytacare Pharmaceutical Co., Ltd. Announces Change of Company Secretary CI
31/05/19 Baytacare Pharmaceutical Co., Ltd. entered into an agreement to acquire 70% stake in Hubei Taofuan Electronics Commerce Co., Ltd. from Taofuan Holdings Co., Ltd. for CNY 1.5 million. CI
15/05/19 Baytacare Pharmaceutical Co., Ltd. Announces Unaudited Consolidated Earnings Results for the First Quarter Ended March 31, 2019 CI
30/04/19 Baytacare Pharmaceutical Co., Ltd. Reports Consolidated Earnings Results for the Year Ended December 31, 2018 CI
24/04/19 Baytacare Pharmaceutical Co., Ltd. Appoints Zhu Tianxiang as Independent Non-Executive Director, Chairman of the Remuneration Committee, Member of the Audit Committee and Member of the Nomination Committee CI
Change 5-day change 1-year change 3-year change Capi.($)
+2.61%+18.00% - - 13.03M
+1.27%+0.71%-13.99%-8.59% 12.6B
+0.61%+1.31%-35.65%-59.61% 4.69B
+1.50%+3.86%-10.98%-13.86% 4.35B
+2.33%-1.29%+8.17%-40.25% 3.77B
+2.98%+1.05%+13.17%-14.61% 3.77B
+1.22%-16.35%-14.63%-22.66% 3.05B
+2.80%-1.52%-13.38%-6.27% 2.99B
+3.15%-0.20%-7.61%-26.86% 2.34B
+3.04%+0.91%-11.05%+24.35% 1.66B
Average +2.15%+0.49%-9.55%-18.71% 4.36B
Weighted average by Cap. +1.78%+0.98%-11.00%-19.52%
Logo Baytacare Pharmaceutical Co., Ltd.
Baytacare Pharmaceutical Co., Ltd., formerly Northeast Tiger Pharmaceutical Co., Ltd., is principally engaged in the sales of pharmaceutical products. The Company mainly operates through two business segments. The Medicines Business segment is engaged in the development, manufacture and sales of medicines. The Chinese Herbs Business segment is engaged in the planting, cultivation and sales of Chinese herbs. The Company mainly conducts its businesses in Mainland China. The Company is also engaged in the investment holding business through its subsidiaries in the People's Republic of China (the PRC). Its principal subsidiary includes Antao County Northeast Tiger Xinxing New Products Co., Limited.
Employees
-
  1. Stock Market
  2. Stocks
  3. 8197 Stock